Prothena | PRTA - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
ALKERMES USD 120.7M 47.44M 2026-06
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amgen USD 1.6B 187M 2026-03
Biogen USD 945.1M 147.6M 2026-06
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Exelixis USD 19.95M 6.53M 2026-03
Incyte USD 104.96M 457K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
MacroGenics USD 9.53M 585K 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Prothena USD 28.94M 11.58M 2025-09
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03